ANCOBON PRESCRIBING INFORMATION PDF

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Zulukora Faezahn
Country: Czech Republic
Language: English (Spanish)
Genre: History
Published (Last): 28 June 2014
Pages: 240
PDF File Size: 14.74 Mb
ePub File Size: 13.34 Mb
ISBN: 432-8-21072-268-7
Downloads: 42186
Price: Free* [*Free Regsitration Required]
Uploader: Vudole

Flucytosine has been associated with hypokalemia. Beraprost The risk or severity of bleeding can be increased when Beraprost is combined with Flucytosine.

Anncobon renal impairment is not a feature but serum levels are above those recommended, the dose should be reduced but the dosing interval should remain the same. The risk or severity of adverse effects can be increased when Flucytosine is combined with Decitabine.

Afelimomab The risk or severity of adverse effects can be increased when Flucytosine is combined with Afelimomab. The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluocortin.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Vedolizumab. Qualitative and quantitative composition 3. The risk or severity of adverse effects can be increased when Etanercept is combined with Flucytosine.

Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Flucytosine. Flucytosine is a fluorinated pyrimidine derivative. The risk or severity of adverse effects can be increased when Flucytosine is combined with Cortivazol.

  HANDBOOK OF CANE SUGAR TECHNOLOGY BY MATHUR PDF

The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Flucytosine. To view the changes to a medicine you must sign up and log in. The risk or severity of bleeding can be increased when Butylphthalide is combined with Flucytosine.

Hydroxytyrosol The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Flucytosine.

PDR Search

Treatment is also appropriate for those undergoing urologic procedures, but fluconazole or amphotericin B is ancobkn preferred agent. Otamixaban The risk or severity of bleeding can be increased when Otamixaban is combined with Flucytosine. Nat Rev Drug Discov.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Brodalumab. The risk or severity of adverse effects can be increased when Daclizumab is combined with Flucytosine. Fibrinolysin The risk or severity of bleeding can be increased when Fibrinolysin is combined with Flucytosine.

Corticotropin The risk or severity of adverse effects can be increased when Flucytosine is combined with Corticotropin. Mometasone The risk or severity of adverse effects can be increased when Mometasone is combined with Flucytosine.

Ancobon (flucytosine) dose, indications, adverse effects, interactions from

The risk or severity pprescribing adverse effects can be increased when Trifluridine is combined with Flucytosine. Clozapine The risk or severity of neutropenia can be increased when Flucytosine is combined with Clozapine. The solution for injection should not be allowed to freeze as precipitation will occur. Flucytosine is deaminated to fluorouracil in fungal cells.

Colchicine The risk or severity of adverse effects can be increased when Flucytosine is combined with Colchicine.

  ESPASMOFEMIA TRATAMIENTO PDF

The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Flucytosine. Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Flucytosine. The risk or severity of adverse effects can be increased when Teniposide is combined with Flucytosine. The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Flucytosine.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Gallium nitrate. The risk or severity of adverse effects can be increased when Flucytosine is combined with Halometasone. Male patients or their female partners of childbearing potential must use effective contraception during treatment and for three months after treatment see section 4. Decitabine The risk or severity of adverse effects can be increased when Flucytosine is combined with Decitabine.

Bone marrow toxicity can be irreversible and may lead to death in immunosuppressed patients.

The risk or severity of adverse effects can be increased when Mometasone is combined with Flucytosine. Flunisolide The risk or severity of adverse effects can be increased when Flunisolide is combined with Flucytosine. Consequently Ancotil should not be used during pregnancy and in women of childbearing potential not using contraception unless strictly necessary in case of life-threatening infections and lack of an effective alternative treatment.